Drew Burdon
Private Equity Investor at EQT Life Sciences Group BV
Profile
Drew Burdon is a Partner in the EQT Life Sciences team.
Drew worked for LSP from 2019 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to joining LSP, Drew worked for 13 years across R&D, commercial/strategy and most recently as a Director of Corporate Development at Smith & Nephew in London, UK.
Prior to Smith & Nephew, Drew was a Senior Scientific Officer, at Cancer Research UK in Leeds, UK.
Drew holds a BSc (Hons) In Medical Biochemistry and a PhD in Cell and Molecular Biology, both from the University of Leicester (UK), as-well as an MBA from the Open University (UK).
Drew Burdon active positions
Companies | Position | Start |
---|---|---|
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Private Equity Investor | 2022-02-27 |
Former positions of Drew Burdon
Companies | Position | End |
---|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Private Equity Investor | 2022-02-27 |
Training of Drew Burdon
University of Leicester | Doctorate Degree |
The Open University Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Finance |
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Finance |
- Stock Market
- Insiders
- Drew Burdon